ImageIQ (Cleveland, OH, USA), an imaging contract research organization (CRO) specializing in advanced medical image acquisition, analysis, and visualization, reported that the company's spinout of technology and expertise will now be developed at Cleveland Clinic Innovations (Cleveland, OH, USA).

Concurrent with the formation of the company, Cleveland Clinic Innovations announced the appointment of Timothy Kulbago as president and CEO of ImageIQ.

ImageIQ combines software, engineering, and imaging expertise for research, medical device, and pharmaceutical organizations. Incubated within Cleveland Clinic over an eight-year period, ImageIQ provides customized image analytics and data analysis, providing objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead, improves grant attractiveness and fundability, and supports regulatory compliance. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities, and complete work quickly, allowing innovative staff members to focus on creative solutions to research.

"I am excited to be part of the ImageIQ team," stated Mr. Kulbago. "We have an opportunity to bring Cleveland Clinic expertise in custom image analysis to the broader market. We have already demonstrated our unique capabilities to several prominent research labs and medical device manufacturers."

"We are pleased to add ImageIQ to our expanding portfolio of companies," said Chris Coburn, executive director of Cleveland Clinic Innovations. "Cleveland is an emerging hub for healthcare IT [information technology] start-ups, and ImageIQ has a compelling blend of software engineering and biomedical expertise. With 15 years of experience as a healthcare innovator and company leader, Tim Kulbago brings the full set of tools to drive ImageIQ to be a market leader."

ImageIQ engineers pair their technical image analysis expertise with their vast experience in deriving solutions for biologically rooted problems to generate unique solutions that are efficient, precise, and accurate. Consequently, research based studies or clinical trials that previously limited dataset sizes to accommodate for time required for pathologist/radiologist reads, are now able to increase study sizes, throughput and statistical power with the aid of tailored Image IQ analysis software. Moreover, ImageIQ offers the option of exporting quantified data in visual form (i.e., superimposed, pseudo-colored two-dimensional [2D]/3D/4D images) for the validation of accuracy by a trained reader (technician/pathologist/radiologist).

Cleveland Clinic Innovations, the corporate venturing arm of Cleveland Clinic, promotes innovation and is responsible for the commercialization of all Cleveland Clinic technologies. Innovations advances product-oriented innovation and transforms promising therapies, devices, diagnostics, and software into beneficial medical products, via spin-off companies, licensees, and equity partnerships. There have been 36 companies spun off from the Clinic in the last 10 years, more than 200 licenses, more than US$450 million in equity investment in those spin-offs and a record number of inventions in virtually every area of activity at Cleveland Clinic.
 

Guangzhou Jia Yu medical equipment Limited